What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
Richard Zigeuner focuses on Urology, Surgery, Bladder cancer, Internal medicine and Carcinoma.
His work carried out in the field of Urology brings together such families of science as Carcinoma in situ and Nomogram.
His studies in Surgery integrate themes in fields like Transitional cell carcinoma, Lymphadenectomy and Genitourinary system.
In his research, Richard Zigeuner undertakes multidisciplinary study on Bladder cancer and Context.
His work investigates the relationship between Internal medicine and topics such as Oncology that intersect with problems in Disease and Pathology.
Richard Zigeuner has researched Carcinoma in several fields, including Radiology, Renal cell carcinoma, Nephrectomy and Chemotherapy.
His most cited work include:
- EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. (1390 citations)
- EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013 (845 citations)
- European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update (670 citations)
What are the main themes of his work throughout his whole career to date?
Internal medicine, Renal cell carcinoma, Oncology, Urology and Surgery are his primary areas of study.
His research in the fields of Proportional hazards model, Cohort, Cancer and Nephrology overlaps with other disciplines such as In patient.
His work carried out in the field of Renal cell carcinoma brings together such families of science as Carcinoma, Metastasis and Nephrectomy.
His research integrates issues of Bladder cancer, Urothelial carcinoma, Carcinoma in situ, Upper urinary tract and Concomitant in his study of Urology.
His work in the fields of Bladder cancer, such as Cystectomy, overlaps with other areas such as Context.
The concepts of his Surgery study are interwoven with issues in Lymphadenectomy, Lymph node, Radiology and Nomogram.
He most often published in these fields:
- Internal medicine (43.65%)
- Renal cell carcinoma (37.57%)
- Oncology (30.66%)
What were the highlights of his more recent work (between 2013-2021)?
- Internal medicine (43.65%)
- Urology (29.83%)
- Renal cell carcinoma (37.57%)
In recent papers he was focusing on the following fields of study:
Richard Zigeuner mainly investigates Internal medicine, Urology, Renal cell carcinoma, Surgery and Nephrectomy.
His Internal medicine study combines topics in areas such as Gastroenterology and Oncology.
His Urology research includes themes of Bladder cancer, Cancer, Cystectomy and Carcinoma in situ.
His Renal cell carcinoma study incorporates themes from Stage, Metastasis and Radiology.
His study in Surgery is interdisciplinary in nature, drawing from both Cancer specific mortality, Multivariate analysis, Lymphovascular invasion and Nomogram.
His Nephrectomy research is multidisciplinary, incorporating elements of Survival rate, Kidney cancer, Inferior vena cava, Thrombus and Renal vein.
Between 2013 and 2021, his most popular works were:
- EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. (1390 citations)
- European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update (670 citations)
- European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update. (304 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Surgery
Richard Zigeuner mainly focuses on Urology, Bladder cancer, Internal medicine, Surgery and Context.
His Urology research incorporates themes from Carcinoma in situ, Cystectomy, Upper urinary tract and Ureterectomy.
His Bladder cancer research incorporates elements of Disease and Family medicine.
Richard Zigeuner combines subjects such as Endocrinology and Pathology with his study of Internal medicine.
In general Surgery study, his work on Retrospective cohort study, Stage, Cuff and Prognostic factor often relates to the realm of Risk criteria, thereby connecting several areas of interest.
His biological study spans a wide range of topics, including Carcinoma and Oncology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
